Long-term Follow-up After Mixed Donor Myeloid Chimerism at 1 Year Post Transplantation for Sickle Cell Disease

This publication has 17 references indexed in Scilit:

• Comparison of Regimens Used for Allogeneic Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease
  Transplantation and Cellular Therapy, 2025
• Female Reproductive Health Outcomes after Hematopoietic Cell Transplantation for Sickle Cell Disease: Is Reduced Intensity Better Than Myeloablative Conditioning?
  Transplantation and Cellular Therapy, 2023
• Gonadal health in recipients of nonmyeloablative hematopoietic stem cell transplantation in children and adolescents with sickle cell disease
  Pediatric Hematology and Oncology, 2022
• Neuropsychological, behavioral, and quality‐of‐life outcomes in children and adolescents with sickle cell disease treated with nonmyeloablative matched sibling donor hematopoietic cell transplantation: A case series
  Pediatric Blood & Cancer, 2022
• Assessment of donor cell engraftment after hematopoietic stem cell transplantation for sickle cell disease: A review of current and future methods
  American Journal of Hematology, 2022
• Conditioning Regimen Trends in Hematopoietic Stem Cell Transplant for Sickle Cell Disease: A Survey from the Sickle Cell Transplant Advocacy and Research Alliance (STAR) Consortium
  Transplantation and Cellular Therapy, 2021
• Hematopoietic Cell Transplantation: Practice Predictions for the Year 2023
  Transplantation and Cellular Therapy, 2021
• Relationship between Mixed Donor–Recipient Chimerism and Disease Recurrence after Hematopoietic Cell Transplantation for Sickle Cell Disease
  Transplantation and Cellular Therapy, 2017
• Nonmyeloablative HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Phenotype
  JAMA, 2014
• Allogeneic Hematopoietic Stem-Cell Transplantation for Sickle Cell Disease
  New England Journal of Medicine, 2009